Safety Precautions and Operating Procedures in an (A)BSL-4 Laboratory: 3. Aerobiology
October 3rd, 2016
14.1K views
As high-consequence pathogens can potentially infect subjects through airborne particles, aerobiology has been increasingly applied in pathogenesis research and medical countermeasure development. We present a detailed visual demonstration of aerobiology procedures during an aerosol challenge in nonhuman primates in an animal biosafety level 4 maximum containment environment.
Overview
This article presents a detailed visual demonstration of aerobiology procedures used during aerosol challenges in nonhuman primates. The focus is on the safety protocols and complexities involved in conducting research on high-consequence pathogens in a biosafety level 4 environment.
Key Study Components
Area of Science
- Aerobiology
- Pathogenesis Research
- Laboratory Safety
Background
- Aerobiology is crucial for understanding airborne transmission of pathogens.
- High-consequence pathogens pose significant risks to health.
- Animal biosafety level 4 laboratories are designed to contain these risks.
- Visual demonstrations aid in educating health administrators and collaborators.
Purpose of Study
- To provide a comprehensive understanding of aerosol procedures in a high-containment laboratory.
- To demonstrate the safety components necessary for conducting aerobiology research.
- To assist in the design of similar laboratory environments.
Methods Used
- Demonstration of aerosol challenge procedures in a Class III biosafety cabinet.
- Use of negative-pressure systems to ensure laboratory safety.
- Testing of rapid transfer port (RTP) equipment for aerosol experiments.
- Collaboration between aerobiologists and aerosol engineers during the demonstration.
Main Results
- Successful demonstration of aerosol procedures in a controlled environment.
- Validation of RTP equipment functionality for safe transport of aerosols.
- Highlighting the importance of safety protocols in high-consequence pathogen research.
- Increased understanding of the complexities involved in aerobiology research.
Conclusions
- Aerobiology research can be conducted safely in biosafety level 4 environments.
- Visual demonstrations are effective for training and collaboration.
- Continued development of safety protocols is essential for laboratory research.
Frequently Asked Questions
What is aerobiology?
Aerobiology is the study of airborne particles, including pathogens, and their impact on health.
Why is biosafety level 4 important?
Biosafety level 4 is crucial for containing high-consequence pathogens that pose significant health risks.
What are the advantages of using negative-pressure systems?
Negative-pressure systems help prevent the escape of harmful aerosols, ensuring laboratory safety.
How does the RTP equipment function?
RTP equipment allows for the safe transfer of aerosols between different areas of the laboratory.
Who collaborates in this research?
Collaboration occurs between aerobiologists and aerosol engineers to ensure effective procedures.
What are the main safety protocols in this study?
Main safety protocols include the use of biosafety cabinets and proper handling of aerosolized pathogens.
Executive Industry Relevance
Conducting aerobiology research in ABSL-4 environments requires rigorous safety protocols to enable mechanistic studies of high-consequence pathogens. This work supports target validation by providing controlled inhalation exposure models that clarify pathogenic mechanisms and inform therapeutic hypotheses. The described procedures enhance predictive confidence in preclinical models by standardizing aerosol delivery and dosimetry.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of therapeutic hypotheses through controlled aerosol challenge in NHPs.
- Scientific Value: Supports biological de-risking by clarifying pathogenic mechanisms via inhalation exposure.
- Scientific Value: Provides functional target validation data for inhaled therapeutics or prophylactics.
Screening & Assay Development
- Scientific Value: Prepares validated biological systems for downstream assay development using exposed NHPs.
- Scientific Value: Addresses assay standardization through reproducible aerosol generation and biosampling.
- Scientific Value: Enables quantitative measurement of inhaled dose via biosampler collection media analysis.
Translational & Preclinical Research
- Scientific Value: Supports disease-relevant systems by modeling human inhalation exposure in NHPs.
- Scientific Value: Ensures translational continuity from discovery through preclinical validation via standardized aerobiology.
- Scientific Value: Informs risk-adjusted advancement decisions by delivering precise inhaled dose data.
Pipeline & Workflow Integration
The method integrates into the discovery continuum from hypothesis testing through lead identification by enabling controlled pathogen exposure and respiratory monitoring.
- Discovery Biology: Supports hypothesis testing and pathway clarification via aerosol challenge in NHPs.
- Screening: Ensures assay readiness through reproducible aerosol generation and biosampler attachment.
- Analytics: Provides respiratory inductive plethysmography (RIP) and biosampler output for comparative condition analysis.
- Translational Research: Connects to preclinical continuity through stable anesthesia verification and vital sign monitoring.
- Enterprise Reuse: Establishes reusable capability for multiple NHP exposures per day once procedures are mastered.
Operational & Enterprise Impact
- Scientific Value: Predictive confidence through precise inhaled dose delivery and respiratory parameter recording.
- Operational Value: Standardization via RTP equipment testing, negative-pressure maintenance, and glove integrity checks.
- Strategic Value: Better go/no-go decisions by controlling variables affecting dosimetry such as temperature and humidity.
- Portfolio Impact: Risk-adjusted prioritization through validated aerosol procedures and biosafety confirmation.
Implementation Considerations
- Requires expertise in aerobiology, aerosol engineering, and comparative medicine for NHP handling.
- Needs Class III biosafety cabinet, RTP, dunk tank, autoclave, and biosampler infrastructure.
- Demands cross-team standardization for equipment transfer, decontamination, and waste handling.
- Involves adaptation considerations for different species beyond NHPs, such as rabbits and mice.
- Includes practical limitations like maintaining adequate anesthesia depth for reliable plethysmography acquisition.
Biopharma FAQs
Why does null hypothesis testing matter for target validation?
Null hypothesis testing enables statistical evaluation of whether observed respiratory changes in NHPs are significant compared to controls, supporting mechanistic de-risking of therapeutic targets.
How does independent variable isolation fit the discovery pipeline?
Isolating variables like aerosol concentration and exposure duration allows researchers to attribute physiological responses specifically to the pathogen, improving target confidence in early discovery.
What quantitative dependent variable measurements enable?
Measurements such as respiratory inductive plethysmography (RIP) data and biosampler-collected media enable quantification of inhaled dose and biological response for predictive modeling.
Why do replication requirements matter for cross-functional collaboration?
Replication ensures consistent aerosol delivery and biosafety performance across teams, supporting reliable data sharing between aerobiology, engineering, and pathology groups.
What statistical analysis capabilities are required before implementation?
Implementation requires capability to analyze RIP bands, export respiratory data, and compare collection media results to establish significant differences between exposure and control groups.
Chapters in this video
0:05
Title
0:52
Nonhuman Primate Transport and Handling: Animal Biosafety Level 4 Suit Laboratory
2:08
Aerobiology: ABSL-4 Cabinet Laboratory
8:33
Results: Biosafety Practices for Aerobiology within an ABSL-4 Suit and ABSL-4 Cabinet Laboratory
10:11
Conclusion
